Summaries
-
NICE guideline
NICE type 2 diabetes in children guideline
This succinct Guidelines summary advises on the appropriate diagnosis and management of type 2 diabetes mellitus in children and young people.
-
NICE guideline
NICE type 1 diabetes in children guideline
This summary includes recommendations on pharmacological therapy, and recognition and management of diabetic ketoacidosis.
-
SIGN guideline
SIGN eating disorders guideline
Covering the management of people with eating disorders of all ages and gender groups
-
Independent professional body guideline
BASHH STIs in young people guideline
Covering assessment, safeguarding, and management of STIs and related conditions in children and young people
-
NICE guideline
NICE fever in under 5s guideline
A summary of the 2021 updated NICE guideline on fever in under 5s, with a ‘traffic light’ approach to assessing risk and features of specific diseases
-
SIGN guideline
SIGN epilepsies in children and young people
An easy-to-read summary of SIGN’s recommendations on the management of epilepsy in children and young people in primary care. Includes recommendations, and good practice and information points
-
NICE guideline
NICE bronchiolitis guideline
A brief summary of the NICE guideline on bronchiolitis in babies and children, including advice on when to refer, and 'red flags' for parents
-
NICE guideline
NICE autism management in children guideline
Guidance for offering support and management of children and young people with autism spectrum disorder
-
Independent professional body guideline
Self Care Forum fever in children fact sheet
A summary of recommendations for advising patients and the public on managing fever in children
-
NICE guideline
NICE eczema in under 12s guideline
An easy-to-follow NICE guideline summary on the management of atopic eczema in children under 12
-
NICE guideline
COVID-19 rapid guideline on immunocompromised children
This summary aims to maximise the safety of children and young people who are immunocompromised during the COVID-19 pandemic
-
NICE guideline
NICE CKS on teething
A summary of the NICE CKS on teething in infants, including recommendations on suspecting teething, differential diagnoses, and management
-
Independent professional body guideline
ROS guideline: vitamin D and bone health in children
A clear summary on the management of vitamin D deficiency in children and young people.
-
Independent professional body guideline
Early identification and referral of liver disease in infants
This Guidelines summary is based on guidance included within the Children’s Liver Disease Foundation Yellow Alert Pack, written to provide general guidelines on the early identification of liver disease in infants and their referral where appropriate.
-
NICE guideline
NICE CKS—cow’s milk allergy in children
What is it? Food allergy describes an adverse immune-mediated response, which occurs when a person is exposed to specific food allergen(s), usually by ingestion and more rarely by inhalation or skin contact Cow’s milk allergy is a reproducible immune-mediated allergic response to one or ...
-
NICE guideline
NICE ADHD guideline
The updated summary covers key points on identification and treatment of ADHD, management, supporting families and carers, and appropriate medication.
-
NICE guideline
NICE CKS on head lice
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Areas covered include: treatment and management, advantages and disadvantages of treatment options, information and advice for those with the condition. Please refer to the full guideline for the complete set of recommendations.
-
NICE guideline
NICE GORD in children guideline
A useful NICE guideline summary on the recognition, diagnosis, and management of GORD in children and young people.
-
-
NICE guideline
NICE depression in children and young people guideline
This summary covers assessing people aged 5–18 years for depression and appropriate management strategies based on severity.